ArticleEcancermedicalscience2018
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
Article in Ecancermedicalscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Prevalence and Risk Factors for Financial Toxicity Among Sarcoma Patients During and Following Treatment Across the Lifespan.Cancer reports (Hoboken, N.J.) · 2026Article
- Dental Treatment Discontinuation for Financial Reasons Among Patients with Cancer: A Cross-Sectional Study with Non-Cancer Controls.Journal of clinical medicine · 2026Article
- PRAISE-H study exploring real-world challenges faced by reproductive-age patients with rheumatoid arthritis in Japan.Frontiers in medicine · 2026Article
- Mapping Disparities in the Measurement of Financial Toxicity in Cancer Care: A Scoping Review.Current oncology reports · 2025Article
- Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer.International journal of clinical oncology · 2025Article
- Cancer survivor preferences on the timing and content of interventions to mitigate financial toxicity associated with cancer treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Influence of age on financial toxicity in cancer patients.Asia-Pacific journal of oncology nursing · 2024Article
- The impact of humanitarian aid on financial toxicity among cancer patients in Northwest Syria.BMC health services research · 2024Article
- Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance.International journal of clinical oncology · 2024Observational
- Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists.Advances in radiation oncology · 2024Review
- Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer.PloS one · 2024Article
- Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.ESMO open · 2023Article
- Heterogeneity of financial toxicity and associated risk factors for older cancer survivors in China.iScience · 2023Article
- Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives.Breast cancer (Tokyo, Japan) · 2023Article
- Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.International journal of clinical oncology · 2023Article
- Quality of life and financial toxicity of hematopoietic stem cell transplant recipients in COVID-19.Revista latino-americana de enfermagem · 2023Article
- Financial toxicity in people with chronic kidney disease undergoing hemodialysis treatment.Revista brasileira de enfermagem · 2023Article
- Cancer treatment-related financial toxicity in Japan: a scoping review.Frontiers in psychology · 2023Article
- Influence of financial burden on withdrawal or change of cancer treatment in Japan: results of a bereavement survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Financial Toxicity Among Older Mexican Adults With Cancer and Their Families: A Mixed-Methods Study.JCO global oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFinancial toxicity (FT) has a negative impact on the quality of life and survival of patients with cancer. The comprehensive score for FT (COST) questionnaire is a tool to measure FT which has already been validated in patients with cancer in the United States. However, the feasibility and validity of assessing FT using the COST questionnaire have not been established in non-US healthcare settings, including that in Japan.
methodsThis is a prospective pilot survey to ascertain the feasibility of using the COST questionnaire to evaluate FT in Japanese patients with advanced solid cancer who had been receiving chemotherapy for at least 2 months. The COST questionnaire was translated into Japanese using Functional Assessment of Chronic Illness Therapy methodology.
resultsOf the 12 patients approached, 11 (92%) responded to the questionnaire. The median COST score was 22 (range, 6-29; mean ± SD, 20.18 ± 8.17). Five (45%) and two (18%) patients suffered grade 1 (COST score 14-25) and grade 2 (COST score 1-13) FT, respectively. The COST measure demonstrated good internal consistency with a Cronbach
conclusionsThe COST measure demonstrated good feasibility in measuring FT in the Japanese healthcare setting. Despite the existing universal health insurance system and ceiling amount for high-cost medical expenses, some Japanese patients experienced meaningful FT during chemotherapy. A prospective study is already underway to confirm the preliminary results (UMIN: 000025043).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.